Coyote Ventures is led by a team with scientific backgrounds—including a GP who worked in biochemistry and product R&D at Impossible Foods and a network of scientist advisors—who review research literature and test products themselves before investing, and they use a relatively large ten-person deal team to make decisions. Rather than limiting themselves to a narrow FemTech label, they back health platforms for conditions that solely, disproportionately, or differently affect women, treating structural issues like missing billing codes and biased research design as real, investable business problems rather than just social ones.